Command Injection Vulnerability in Moxa OnCell and AWK Series Devices
CVE-2016-8363

10CRITICAL

Key Information:

Vendor

Moxa
Status
Moxa Oncell
Vendor
CVE Published:
13 February 2017

What is CVE-2016-8363?

A command injection vulnerability has been identified in Moxa's OnCell and AWK Series devices, allowing an attacker to execute arbitrary operating system commands on the affected devices. This issue presents significant security risks, potentially enabling unauthorized access and control over critical systems. It is essential for users and organizations leveraging these devices to implement immediate security measures and stay updated with vendor advisories to mitigate potential exploitation.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Moxa OnCell Moxa OnCell

References

https://ics-cert.us-cert.gov/advisories/ICSA-16-308-01
x_refsource_MISC
http://www.securityfocus.com/bid/94092
vdb-entryx_refsource_BID

CVSS V3.1

Score:
10
Severity:
CRITICAL
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.